Yanru Wang
Clinical trials sponsored by Yanru Wang, explained in plain language.
-
New 'Off-the-Shelf' cell therapy tested for aggressive lymphomas
Disease control Not yet recruitingThis is an early-stage study to test the safety and initial effectiveness of a new cell therapy called RN1701 for people with B-cell lymphoma that has come back or not responded to other treatments. Up to 19 participants will receive the therapy, which involves immune cells engin…
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Early trial tests 'Ready-Made' cell therapy for tough blood cancers
Disease control Not yet recruitingThis is an early safety study testing a new type of cell therapy for adults with B-cell blood cancers that have returned or not responded to standard treatments. The therapy, called 19UCART, uses genetically modified immune cells from a donor (not the patient) to target and kill …
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC